Literature DB >> 9869477

Relation of myocardial perfusion at rest and during pharmacologic stress to the PET patterns of tissue viability in patients with severe left ventricular dysfunction.

M F Di Carli1, F Asgarzadie, H R Schelbert, R C Brunken, S Rokhsar, J Maddahi.   

Abstract

BACKGROUND: Stress perfusion imaging can assess effectively the amount of jeopardized myocardium, but its use for identifying underperfused but viable myocardium has yielded variable results. We evaluated the relation between measurements of myocardial perfusion at rest and during pharmacologic stress and the patterns of tissue viability as determined by positron emission tomographic (PET) imaging. METHODS AND
RESULTS: We studied 33 patients with coronary artery disease and left ventricular (LV) dysfunction (LV ejection fraction, 30%+/-8%). PET imaging was used to evaluate regional myocardial perfusion at rest and during pharmacologic stress with [13N]-ammonia as a flow tracer, and to delineate patterns of tissue viability (i.e., perfusion-metabolism mismatch or match) using [18F]-deoxyglucose (FDG). We analyzed 429 myocardial regions, of which 229 were dysfunctional at rest. Of these, 30 had normal perfusion and 199 were hypoperfused. A severe resting defect (deficit >40% below normal) predicted lack of significant tissue viability; 31 of 35 regions (89%) had a PET match pattern denoting transmural fibrosis. Although regions with mild or moderate resting defects (deficit <40% below normal) showed evidence of metabolic activity, perfusion measurements alone failed to identify regions with PET mismatch (reflecting hibernating myocardium). Reversible stress defects were observed with slightly higher frequency in regions with a PET mismatch (10 of 37) than in those with a PET match (36 of 162) pattern of viability. A reversible stress defect was a specific (78%) marker, but was a relatively insensitive marker (27%) of viable myocardium as defined by the PET mismatch pattern.
CONCLUSIONS: In patients with LV dysfunction, the severity of regional contractile abnormalities correlates with the severity of flow deficit at rest. Severe reductions in resting blood flow in these dysfunctional regions identify predominantly nonviable myocardium that is unlikely to have improved function after revascularization. Although dysfunctional myocardium with mild to moderate flow reductions contains variable amounts of viable tissue (as assessed by FDG uptake), flow measurements alone do not distinguish between regions with PET mismatch (potentially reversible dysfunction) and PET match (irreversible dysfunction). The presence of an irreversible defect on stress imaging is a relatively specific (78%) marker of PET match, whereas a reversible stress defect is a rather insensitive (27%) marker of viability, as defined by the PET mismatch pattern.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9869477     DOI: 10.1016/s1071-3581(98)90109-x

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  26 in total

Review 1.  Myocardial 'stunning' in man.

Authors:  R Bolli
Journal:  Circulation       Date:  1992-12       Impact factor: 29.690

2.  Value of thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery bypass grafting.

Authors:  H Ohtani; N Tamaki; Y Yonekura; I H Mohiuddin; K Hirata; T Ban; J Konishi
Journal:  Am J Cardiol       Date:  1990-08-15       Impact factor: 2.778

3.  Pathophysiology of chronic left ventricular dysfunction. New insights from the measurement of absolute myocardial blood flow and glucose utilization.

Authors:  N V Marinho; B E Keogh; D C Costa; A A Lammerstma; P J Ell; P G Camici
Journal:  Circulation       Date:  1996-02-15       Impact factor: 29.690

4.  Positron emission tomographic measurements of absolute regional myocardial blood flow permits identification of nonviable myocardium in patients with chronic myocardial infarction.

Authors:  H Gewirtz; A J Fischman; S Abraham; M Gilson; H W Strauss; N M Alpert
Journal:  J Am Coll Cardiol       Date:  1994-03-15       Impact factor: 24.094

5.  Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization.

Authors:  K Yoshida; K L Gould
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

6.  The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow.

Authors:  K A Reimer; R B Jennings
Journal:  Lab Invest       Date:  1979-06       Impact factor: 5.662

7.  Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy.

Authors:  M F Di Carli; F Asgarzadie; H R Schelbert; R C Brunken; H Laks; M E Phelps; J Maddahi
Journal:  Circulation       Date:  1995-12-15       Impact factor: 29.690

8.  Reversibility of cardiac wall-motion abnormalities predicted by positron tomography.

Authors:  J Tillisch; R Brunken; R Marshall; M Schwaiger; M Mandelkern; M Phelps; H Schelbert
Journal:  N Engl J Med       Date:  1986-04-03       Impact factor: 91.245

9.  Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography.

Authors:  D Eitzman; Z al-Aouar; H L Kanter; J vom Dahl; M Kirsh; G M Deeb; M Schwaiger
Journal:  J Am Coll Cardiol       Date:  1992-09       Impact factor: 24.094

10.  Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging.

Authors:  V Dilsizian; T P Rocco; N M Freedman; M B Leon; R O Bonow
Journal:  N Engl J Med       Date:  1990-07-19       Impact factor: 91.245

View more
  5 in total

Review 1.  Multimodality imaging for assessment of myocardial viability: nuclear, echocardiography, MR, and CT.

Authors:  James A Arrighi; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

2.  Myocardial viability: seeking relevance and redefinition.

Authors:  J A Arrighi; R Soufer
Journal:  J Nucl Cardiol       Date:  1998 Nov-Dec       Impact factor: 5.952

3.  Myocardial Scar But Not Ischemia Is Associated With Defibrillator Shocks and Sudden Cardiac Death in Stable Patients With Reduced Left Ventricular Ejection Fraction.

Authors:  Ankur Gupta; Meagan Harrington; Christine M Albert; Navkaranbir S Bajaj; Jon Hainer; Victoria Morgan; Courtney F Bibbo; Paco E Bravo; Michael T Osborne; Sharmila Dorbala; Ron Blankstein; Viviany R Taqueti; Deepak L Bhatt; William G Stevenson; Marcelo F Di Carli
Journal:  JACC Clin Electrophysiol       Date:  2018-07-25

4.  The suitability of gamma camera coincidence systems for nitrogen 13-labeled ammonia myocardial perfusion imaging: a quantitative comparison with full-ring PET.

Authors:  Fergus I McKiddie; Howard G Gemmell; E Joyce Davidson; Andrew Welch; Mohaned Egred
Journal:  J Nucl Cardiol       Date:  2003 Nov-Dec       Impact factor: 5.952

5.  Myocardial perfusion and glucose uptake coupling in CAD patients.

Authors:  Alejandro N Mazzadi; Pierre Croisille; Xavier André-Fouët; Stéphane Fol; Jérôme Duisit; Michel Ovize; Dominique Comar; Marc F Janier
Journal:  Int J Cardiovasc Imaging       Date:  2003-10       Impact factor: 2.357

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.